medicare coverage of glp 1 for weight loss Bridge Program Explained: GLP-1 Medications Navigating Medicare's $50 GLP-1 Program:

& Bird, G

Lilly sells it under one global brand, Mounjaro

This includes: Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Dulaglutide (Trulicity) Liraglutide (Saxenda) Most prescribing information suggests discontinuing these medications at least 2 months before attempting conception due to potential fetal harm observed in animal studies, including: Growth restriction Delayed skeletal development Increased pregnancy loss There is limited human data, but the risk signals are sufficient to justify a cautious, prevention-first approach

This could become an increasing problem as reports of side effects surface, particularly GI symptoms

Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons